journal article·2024-10Open access

Nanostructured cruciform phototheranostic agents for efficient multimodal imaging-guided type I photodynamic/photothermal synergistic therapy

Yunhui Liao, Yali Mai, Xinchun Liu, Zhaoji Wu, Shaozhen Wang, Benzhen Xie, Yue Gong, Yifan Xie, Zhen Fang, Jiayu Wu, Longquan Shao, Wanshan Wang, Yanshan Liu

Dyes and Pigments· Volume 229

Abstract

One-component multimodel imaging-guided synergistic platform provides an attracting strategy for the precise cancer therapy. However, the construction of single molecules integrating near-infrared (NIR) II emission, multimodel-imaging and multiple therapeutic modalities still remains a great challenge. In this study, a series of organic phototheranostic agents (named PMY , MePMY and TPMY ) based on a cross-shaped D- π -A framework were designed and synthesized, and their corresponding nanoparticles (NPs) were facilely fabricated by encapsulating them with an amphiphilic polymer. The twisted structure and lower band gaps of these compounds extended their emissions deep into the NIR-II region, and the narrow singlet-triplet energy gaps endowed them with highly efficient intersystem crossing from S 1 to T 1 state. Specifically, TPMY NPs exhibit NIR-II emission at 1022 nm, efficient generation of type I reactive oxygen species , and high photothermal conversion efficiency (37.8 %), as well as good photostability and biocompatibility . In vitro and in vivo experiments further revealed the excellent photoacoustic and photothermal imaging ability and superior tumoricidal activity of TPMY NPs, in which the tumor growth was effectively inhibited or even completely eradicated upon single administration and once light irradiation . This study thus provides a new insight into the design and development of intelligent phototheranostic agents for multimodel imaging-guided synergistic therapy which has potential in future practical applications.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Photoacoustic and Ultrasonic Imaging

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (63)

Show source-provided references
1. Cancer statistics, 202310.3322/caac.21763 ↗
2. Clinical development and potential of photothermal and photodynamic therapies for cancer10.1038/s41571-020-0410-2 ↗
3. Recent advances in fluorescence imaging-guided photothermal therapy and photodynamic therapy for cancer: from near-infrared-I to near-infrared-II10.1016/j.jconrel.2023.08.056 ↗
4. In response to precision medicine: current subcellular targeting strategies for cancer therapy10.1002/adma.202209529 ↗
5. Gathering brings strength: how organic aggregates boost disease phototheranostics10.1002/agt2.25 ↗
6. High performance one-for-all phototheranostics: NIR-II fluorescence imaging guided mitochondria-targeting phototherapy with a single-dose injection and 808 nm laser irradiation10.1016/j.biomaterials.2019.119671 ↗
7. A mitochondria-targeted NIR-II molecule fluorophore for precise cancer phototheranostics10.1021/acs.jmedchem.3c01677 ↗
8. Highly efficient multifunctional organic photosensitizer with aggregation-induced emission for in vivo bioimaging and photodynamic therapy10.1021/acsami.1c17476 ↗
9. The concept and examples of type-III photosensitizers for cancer photodynamic therapy10.1016/j.chempr.2021.10.006 ↗
10. Activatable polymer nanoagonist for second near-infrared photothermal immunotherapy of cancer10.1038/s41467-021-21047-0 ↗
11. Overcoming the Achilles' Heel of photodynamic therapy10.1039/C6CS00616G ↗
12. Organelle-targeted photosensitizers for precision photodynamic therapy10.1021/acsami.1c02019 ↗
13. Imaging and photodynamic therapy: mechanisms, monitoring and optimization10.1021/cr900300p ↗
14. Nanostructured phthalocyanine assemblies with efficient synergistic effect of type I photoreaction and photothermal action to overcome tumor hypoxia in photodynamic therapy10.1021/jacs.1c07479 ↗
15. Photocaged DNA-binding photosensitizer enables photocontrol of nuclear entry for dual-targeted photodynamic therapy10.1021/acs.jmedchem.2c01504 ↗
16. Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy10.1039/C6CS00271D ↗
17. A light-triggered self-reinforced nanoagent for targeted chemophotodynamic therapy of breast cancer bone metastases via ER stress and mitochondria mediated apoptotic pathways10.1016/j.jconrel.2019.12.043 ↗
18. Near-infrared photodynamic and photothermal co-therapy based on organic small molecular dyes10.1186/s12951-023-02111-x ↗
19. A lysosomes and mitochondria dual-targeting AIE-active NIR photosensitizer: constructing amphiphilic structure for enhanced antitumor activity and two-photon imaging
20. Good steel used in the blade: well-tailored type-I photosensitizers with aggregation-induced emission characteristics for precise nuclear targeting photodynamic therapy10.1002/advs.202100524 ↗
21. An updated overview on the development of new photosensitizers for anticancer photodynamic therapy10.1016/j.apsb.2017.09.003 ↗
22. Specific core-satellite nanocarriers for enhanced intracellular ROS generation and synergistic photodynamic therapy10.1021/acsami.9b16934 ↗
23. Innovative strategies for hypoxic-tumor photodynamic therapy10.1002/anie.201805138 ↗
24. Strategies to improve photodynamic therapy efficacy by relieving the tumor hypoxia environment10.1038/s41427-021-00303-1 ↗
25. Hypoxia-responsive photosensitizer targeting dual organelles for photodynamic therapy of tumors
26. An unexpected strategy to alleviate hypoxia limitation of photodynamic therapy by biotinylation of photosensitizers10.1038/s41467-022-29862-9 ↗
27. Covalent organic nanosheets integrated heterojunction with two strategies to overcome hypoxic-tumor photodynamic therapy10.1021/acs.chemmater.9b00265 ↗
28. Recent progress in type I aggregation-induced emission photosensitizers for photodynamic therapy10.3390/molecules28010332 ↗
29. Type I photosensitizers revitalizing photodynamic oncotherapy10.1002/smll.202006742 ↗
30. Organic molecule-based photothermal agents: an expanding photothermal therapy universe10.1039/C7CS00522A ↗
31. Multifunctional phototheranostic nanomedicine for cancer imaging and treatment
32. Low temperature photothermal therapy: advances and perspectives10.1016/j.ccr.2021.214330 ↗
33. Nanomaterials for photothermal and photodynamic cancer therapy10.1063/5.0047672 ↗
34. A dual-targeted organic photothermal agent for enhanced photothermal therapy10.1002/anie.201811273 ↗
35. 2-Dicyanomethylenethiazole based NIR absorbing organic nanoparticles for photothermal therapy and photoacoustic imaging10.1039/C9TB00808J ↗
36. Fluorescent silicon nanorods-based nanotheranostic agents for multimodal imaging-guided photothermal therapy10.1007/s40820-019-0306-9 ↗
37. Ce6-modified carbon dots for multimodal-imaging-guided and single-NIR-laser-triggered photothermal/photodynamic synergistic cancer therapy by reduced irradiation power10.1021/acsami.8b19042 ↗
38. Near-infrared small molecule coupled with rigidness and flexibility for high-performance multimodal imaging-guided photodynamic and photothermal synergistic therapy10.1039/D0NH00672F ↗
39. Biocompatible semiconducting polymer nanoparticles as robust photoacoustic and photothermal agents revealing the effects of chemical structure on high photothermal conversion efficiency10.1016/j.biomaterials.2018.07.042 ↗
40. Mitochondria-targeting phototheranostics by aggregation-induced NIR-II emission luminogens: modulating intramolecular motion by electron acceptor engineering for multi-modal synergistic therapy10.1002/adfm.202110526 ↗
41. Photothermal-pH-hypoxia responsive multifunctional nanoplatform for cancer photo-chemo therapy with negligible skin phototoxicity10.1016/j.biomaterials.2019.119422 ↗
42. Emerging photothermal-derived multimodal synergistic therapy in combating bacterial infections10.1039/D1CS00074H ↗
43. Nanotechnology for multimodal synergistic cancer therapy10.1021/acs.chemrev.7b00258 ↗
44. Chemical design and synthesis of functionalized probes for imaging and treating tumor hypoxia10.1021/acs.chemrev.6b00525 ↗
45. An all-round athlete on the track of phototheranostics: subtly regulating the balance between radiative and nonradiative decays for multimodal imaging-guided synergistic therapy10.1002/adma.202003210 ↗
46. All-in-one phototheranostics: single laser triggers NIR-II fluorescence/photoacoustic imaging guided photothermal/photodynamic/chemo combination therapy10.1002/adfm.201901480 ↗
47. Synergistic upconversion photodynamic and photothermal therapy under cold near-infrared excitation10.1016/j.jcis.2021.05.017 ↗
48. Theranostic nanomotors for tumor multimode imaging and photothermal/photodynamic synergistic therapy10.1016/j.cej.2022.135994 ↗
49. Camouflaged gold nanodendrites enable synergistic photodynamic therapy and NIR biowindow II photothermal therapy and multimodal imaging10.1021/acsami.1c01238 ↗
50. Biodegradable hollow Co3S4@N-doped carbon as enhanced PTT/PDT agent for multimodal MR/thermal imaging and synergistic antitumor therapy
51. Add the finishing touch: molecular engineering of conjugated small molecule for high-performance AIE luminogen in multimodal phototheranostics10.1002/smll.202102044 ↗
52. Self-assembled metallacage with second near-infrared aggregation-induced emission for enhanced multimodal theranostics10.1021/jacs.2c03895 ↗
53. 9,10-Phenanthrenequinone: a promising kernel to develop multifunctional antitumor systems for efficient type I photodynamic and photothermal synergistic therapy10.1021/acsnano.1c07730 ↗
54. Precise molecular engineering of small organic phototheranostic agents toward multimodal imaging-guided synergistic therapy10.1021/acsnano.1c00585 ↗
55. One-for-all phototheranostic agent based on aggregation-induced emission characteristics for multimodal imaging-guided synergistic photodynamic/photothermal cancer therapy10.1021/acsami.1c02260 ↗
56. A mitochondria-targeted NIR-II molecule fluorophore for precise cancer phototheranostics10.1021/acs.jmedchem.3c01677 ↗
57. One-for-all phototheranostics: single component AIE dots as multi-modality theranostic agent for fluorescence-photoacoustic imaging-guided synergistic cancer therapy10.1016/j.biomaterials.2021.120892 ↗
58. Facile synthesis of biocompatible L-cysteine-modified MoS2 nanospheres with high photothermal conversion efficiency for photothermal therapy of tumor10.1016/j.msec.2020.111371 ↗
59. Copper selenide nanocrystals for photothermal therapy10.1021/nl201400z ↗
60. Indirect detection of photosensitizer ex vivo10.1016/S1011-1344(02)00279-8 ↗
61. Crystal structures and emission properties of the BF2 complex 1-phenyl-3-(3,5-dimethoxyphenyl)-propane-1,3-dione: multiple chromisms, aggregation- or crystallization-induced emission, and the self-assembly effect10.1021/ja501977a ↗
62. Metal-free sensitizers containing hydantoin acceptor as high performance anchoring group for dye-sensitized solar cells10.1002/adfm.201601305 ↗
63. Molecular engineering of near-infrared-II photosensitizers with steric-hindrance effect for image-guided cancer photodynamic therapy10.1002/adfm.202008356 ↗